From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes via a handful of filings by Michael K. Hooks, executive chair of Malibu Boats Inc $MBUU.
Hooks reported a purchase of $535,250 on his one stock.
Expert technical analysis of financial markets by JC Parets
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes via a handful of filings by Michael K. Hooks, executive chair of Malibu Boats Inc $MBUU.
Hooks reported a purchase of $535,250 on his one stock.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes via a handful of filings by Maplebear Inc $CART director Ravi Gupta.
Gupta reported a total purchase of $57 million in CART.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes via a handful of filings by the CEO and chairman of OPKO Health $OPK, Phillip Frost.
Frost reported a total purchase of 1,000,000 OPK shares, equivalent to $991,700.
by David
This is the video recording of the February 21, 2024, Hot Corner Insider Weekly Strategy Session.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Keith Crandell, the co-founder and a managing director of ARCH Venture Partners.
ARCH Venture Partners just bought 3,200,000 shares of Prime Medicine Inc $PRME, equivalent to $20 million.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Deerfield Asset Management’s James Flynn.
The investment firm reported a purchase of $37 million in Larimar Therapeutics $LRMR.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by RxSight Inc $RXST director Juliet Tammenoms Bakker.
Bakker reported a purchase of $406,672 in RXST.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by David Goeddel, director of Tenaya Therapeutics Inc $TNYA.
Goeddel reported a purchase of 2,222,222 TNYA shares, equivalent to $10 million.